Aspira Pathlab Quarterly Results
Aspira Pathlab quarterly results. In Mar 2025, Aspira Pathlab (ASPIRA) reported revenue ₹6 Cr and net profit ₹1 Cr — revenue +50.0% YoY. Check ASPIRA market value to track the company's total market size over time.
ASPIRA Quarterly Results — Revenue, Profit & EPS Highlights
Aspira Pathlab latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit ASPIRA share price.
- Revenue of ₹6 Cr in Mar 2025 (+20.0% vs Jun 2025, +50.0% vs Mar 2024)
- Net Profit of ₹1 Cr in Mar 2025 (+200.0% vs Mar 2024)
- EBITDA of ₹1 Cr in Mar 2025 (+0.0% vs Jun 2025)
- Operating Margin of 16.0% in Mar 2025 (+3.0pp vs Jun 2025)
- Earnings Per Share of ₹0.66 in Mar 2025 (+61.0% vs Jun 2025)
Aspira Pathlab Quarterly Results — Revenue, EBITDA, Net Profit & EPS
ASPIRA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 6 | 5 | 6 | 4 | 5 | 20.0% | 50.0% |
| Net Profit (₹ Cr) | 1 | 0 | 1 | -1 | 0 | - | - |
| EBITDA (₹ Cr) | 1 | 1 | 1 | 0 | 0 | - | - |
| EPS (₹) | 0.66 | 0.41 | 0.96 | -0.49 | 0.05 | - | - |
| Operating Margin (%) | 16.0% | 13.0% | 21.0% | -5.0% | 6.0% | - | - |
ASPIRA Share Price Trend — 1-Year Movement Across Quarterly Results
Aspira Pathlab 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Review ASPIRA earnings multiple to evaluate earnings-based valuation against sector peers.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
ASPIRA vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap
Aspira Pathlab latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Apollo Hospitals
Mar 2026 |
₹116,947.25 Cr | 7914.5 | 6,660 | 551 | -6.3% | - | 8.3% | 215.0 |
|
Max Healthcare Inst…
Mar 2026 |
₹87,841.25 Cr | 902.5 | 2,191 | 342 | -9.0% | - | 15.6% | 256.4 |
|
Fortis Healthcare
Mar 2026 |
₹57,663.70 Cr | 764.0 | 2,375 | 271 | -7.7% | - | 11.4% | 217.0 |
|
Aster DM Healthcare
Mar 2026 |
₹42,146.56 Cr | 684.7 | 1,219 | 154 | -0.6% | +18.1% | 12.6% | 251.7 |
|
Global Health
Mar 2026 |
₹38,047.48 Cr | 1300.8 | 1,196 | 142 | -9.8% | - | 11.9% | 242.7 |
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores